mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.007 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.007 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.007 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |